Nomura Holdings Inc Gilead Sciences, Inc. Transaction History

Nomura Holdings Inc

$50.5 Billion
Q2 2024

A detailed history of Nomura Holdings Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nomura Holdings Inc holds 127,454 shares of GILD stock, worth $11.2 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

127,454

Previous 32,677 290.04%

Holding current value

$11.2 Million

Previous $2.39 Million 265.4%

% of portfolio

0.02%

Previous 0.01%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$63.15 - $72.88 $5.99 Million - $6.91 Million	94,777 Added 290.04%	127,454 $8.74 Million
Q1 2024 May 15, 2024	BUY	$71.58 - $87.29 $2.34 Million - $2.85 Million	32,677 New	32,677 $2.39 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $701,999 - $796,085	9,581 Added 108.6%	18,403 $1.49 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $190,469 - $207,805	-2,576 Reduced 22.6%	8,822 $661,000
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $513,979 - $586,265	-6,762 Reduced 37.24%	11,398 $878,000
Q1 2023 May 15, 2023	BUY	$77.31 - $88.08 $1.37 Million - $1.56 Million	17,679 Added 3675.47%	18,160 $1.51 Million
Q4 2022 Feb 14, 2023	BUY	$62.32 - $89.47 $29,975 - $43,035	481 New	481 $40,000
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $2.14 Million - $2.41 Million	-37,074 Reduced 80.32%	9,081 $589,000
Q1 2022 May 18, 2022	SELL	$57.92 - $72.58 $11.5 Million - $14.4 Million	-198,981 Reduced 81.17%	46,155 $2.89 Million
Q4 2021 Feb 14, 2022	BUY	$64.88 - $73.64 $9.19 Million - $10.4 Million	141,637 Added 136.85%	245,136 $17.9 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $2.26 Million - $2.43 Million	33,318 Added 47.47%	103,499 $7.23 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $3.68 Million - $4.03 Million	58,041 Added 478.1%	70,181 $4.92 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $4.91 Million - $5.6 Million	-81,837 Reduced 87.08%	12,140 $808,000
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $2.37 Million - $2.7 Million	41,842 Added 80.26%	93,977 $5.7 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $3.06 Million - $3.84 Million	49,234 Added 1697.14%	52,135 $3.43 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $8.23 Million - $9.55 Million	-113,732 Reduced 97.51%	2,901 $225,000
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $31.5 Million - $34.6 Million	-510,613 Reduced 81.41%	116,633 $7.63 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $20 Million - $22.1 Million	-319,636 Reduced 33.76%	627,246 $40.2 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $38.9 Million - $43.6 Million	629,035 Added 197.9%	946,882 $63.7 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $8.34 Million - $9.34 Million	-133,299 Reduced 29.55%	317,847 $20.9 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $17.1 Million - $22.3 Million	282,344 Added 167.26%	451,146 $28.4 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $8.15 Million - $9.03 Million	-114,362 Reduced 40.39%	168,802 $13.1 Million
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $150,975 - $176,107	-2,327 Reduced 0.82%	283,164 $14 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $26.1 Million - $31.8 Million	-358,342 Reduced 55.66%	285,491 $21.7 Million
Q1 2018 May 14, 2018	BUY	$72.84 - $88.8 $20.8 Million - $25.4 Million	285,491 Added 79.67%	643,833 $47.8 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $2.22 Million - $2.6 Million	31,154 Added 9.52%	358,342 $26.1 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $23.6 Million - $28 Million	327,188	327,188 $26.6 Million

Others Institutions Holding GILD

# of Institutions

1,893

Shares Held

1.02B

Call Options Held

12M

Put Options Held

8.96M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $110B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Account

Nomura Holdings Inc Gilead Sciences, Inc. Transaction History